Spontaneous Regression of Uterine Arteriovenous Malformations with Conservative Management
- PMID: 28299220
- PMCID: PMC5337316
- DOI: 10.1155/2017/6437670
Spontaneous Regression of Uterine Arteriovenous Malformations with Conservative Management
Abstract
Uterine arteriovenous malformation (AVM) can cause massive hemorrhage and is often treated with uterine artery embolization (UAE), which may lead to ovarian insufficiency. Thus, avoiding UAE should be considered, particularly in women undergoing fertility treatments. We present three women diagnosed with postmiscarriage AVM on color Doppler by transvaginal ultrasound imaging. They had no genital bleeding and a small mass, measuring 16-22 mm. If estradiol was >300 pg/mL when AVM was diagnosed, then a gonadotropin-releasing hormone agonist was administered. All three women underwent follow-up observation, revealing spontaneous mass disappearance. To avoid ovarian insufficiency risk with UAE, conservative management and close follow-up observation should be considered in patients with AVM without bleeding, particularly during the fertility treatment.
Conflict of interest statement
The authors declare that there is no conflict of interests regarding the publication of this paper.
Figures





Similar articles
-
Resolution of Uterine Arteriovenous Malformation and Maintenance of Reproduction in 20 Women Treated with a GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid.J Obstet Gynaecol Can. 2019 Jun;41(6):772-781. doi: 10.1016/j.jogc.2018.07.018. Epub 2018 Nov 7. J Obstet Gynaecol Can. 2019. PMID: 30413336
-
Effect of gonadotropin-releasing hormone agonist on a uterine arteriovenous malformation.Obstet Gynecol. 2006 Sep;108(3 Pt 2):751-3. doi: 10.1097/01.AOG.0000191584.28717.2c. Obstet Gynecol. 2006. PMID: 17018490
-
Disappearance of a uterine arteriovenous malformation following long-term administration of oral norgestrel/ethinyl estradiol.J Obstet Gynaecol Res. 2014 Jun;40(6):1807-10. doi: 10.1111/jog.12370. J Obstet Gynaecol Res. 2014. PMID: 24888954
-
Use of three-dimensional power Doppler sonography in the diagnosis of uterine arteriovenous malformation and follow-up after uterine artery embolization: Case report and brief review of literature.J Clin Ultrasound. 2015 Jun;43(5):327-34. doi: 10.1002/jcu.22210. Epub 2014 Jul 18. J Clin Ultrasound. 2015. PMID: 25042165 Review.
-
Transcatheter embolization of uterine arteriovenous malformation: report of 2 cases and review of literature.J Minim Invasive Gynecol. 2011 Nov-Dec;18(6):812-9. doi: 10.1016/j.jmig.2011.07.007. J Minim Invasive Gynecol. 2011. PMID: 22024270 Review.
Cited by
-
Retained Placenta Percreta with Acquired Uterine Arteriovenous Malformation-Case Report and Short Review of the Literature.Diagnostics (Basel). 2022 Apr 5;12(4):904. doi: 10.3390/diagnostics12040904. Diagnostics (Basel). 2022. PMID: 35453952 Free PMC article.
-
Multimodality imaging in secondary postpartum or postabortion hemorrhage: retained products of conception and related conditions.Jpn J Radiol. 2018 Jan;36(1):12-22. doi: 10.1007/s11604-017-0687-y. Epub 2017 Oct 19. Jpn J Radiol. 2018. PMID: 29052024 Review.
-
Congenital uterine arteriovenous malformation presenting as vaginal bleeding following vaginal delivery in a 23-year-old woman: A case report.Case Rep Womens Health. 2023 Mar 2;37:e00493. doi: 10.1016/j.crwh.2023.e00493. eCollection 2023 Mar. Case Rep Womens Health. 2023. PMID: 36915294 Free PMC article.
-
Spontaneous Resolution of an Acquired Uterine Arteriovenous Malformation in an Elderly Primigravida.Am J Case Rep. 2018 Sep 27;19:1140-1145. doi: 10.12659/AJCR.909635. Am J Case Rep. 2018. PMID: 30258044 Free PMC article.
-
A comprehensive diagnostic approach to differentiate intrauterine arteriovenous malformation in cases of enhanced myometrial vascularity.Arch Gynecol Obstet. 2024 Nov;310(5):2523-2529. doi: 10.1007/s00404-024-07754-1. Epub 2024 Sep 28. Arch Gynecol Obstet. 2024. PMID: 39340553
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources